In addition, the observation that reconstitution of the ZEB1+/- cells with exogenous ZEB1 caused them to regain a wild type-like (ZEB1+/+) gene expression profile was particularly notable evidence for the potential utility of gene therapy for PPCD. The gene discussed is ZEB1; the disease is posterior polymorphous corneal dystrophy.